CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): 10-Q filed May 7, 2025

AI analysis of the 10-Q that CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed with the U.S. SEC on May 7, 2025, grounded in the primary-source EDGAR filing.

• Material Collection Risk: Extended trade receivables aging (up to 898 days) signals significant collection challenges that pose immediate cash flow concerns for Q1 2025 and could strain working capital management.

• Earnings Volatility: Three-segment revenue model with mixed recognition methods (over time vs. point in time) creates unpredictable earnings patterns; performance heavily dependent on customer and contract mix concentrations.

• Macro Headwinds: Multi-geography exposure (US, Europe, Canada, Asia-Pacific) leaves company vulnerable to currency fluctuations and regional economic downturns amid current macroeconomic uncertainty.

• Limited Visibility: Management provides neutral tone with low confidence (0.15 sentiment score), suggesting cautious outlook and insufficient guidance on near-term performance trajectory.

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)'s 10-Q filed May 7, 2025 say?

Quarterly Period Covered: Q1 2025 fiscal year (December 29, 2024 through March 29, 2025), filed May 7, 2025 Company Business: Commercial physical and biological research services provider; operates as a publicly traded company (CIK: 0001100682) headquartered in Wilmington, Massachusetts Financial Reporting Structure: Filing includes consolidated financial statements with segment reporting broken…

Is CRL's 10-Q bullish or bearish?

Our analysis rates this filing CAUTIOUS. Charles River Laboratories faces an elevated but manageable concern profile driven primarily by working capital and operational concentration risks. The most material issue is the extended trade receivables aging (898 and 546 days), which signals either…

How concerning is CRL's latest 10-Q?

Concern level: HIGH (6.2/10). Key factors: Extended trade receivables aging with 898-day and 546-day arrears durations indicates material collection challenges and working capital pressure; Three new risks identified with moderate-to-high severity (avg 5/10), including segment revenue concentration and geographic exposure volatility; Trade receivables collection risk severity escalated from…

What are the main risks flagged in CRL's 10-Q?

Notable risk changes: Extended trade receivables aging with 898-day and 546-day arrears durations disclosed - indicates material collection challenges that could impact Q1 2025 cash flow and working capital; Three-segment business model with mixed revenue recognition timing (over time vs. point in time) creates earnings volatility and potential concentration risks depending on customer/contract mix; Multi-geography…

About this analysis

Primary source:
View this 10-Q on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
May 7, 2025
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.